Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000–01
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 48 (1) , 56-65
- https://doi.org/10.1016/s0163-4453(03)00123-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Fluoroquinolone Resistance inStreptococcus pyogenesClinical Infectious Diseases, 2003
- Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000Journal of Antimicrobial Chemotherapy, 2002
- Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycinJournal of Antimicrobial Chemotherapy, 2002
- Community-Acquired Lower Respiratory Tract InfectionsChest, 2001
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.Journal of Antimicrobial Chemotherapy, 2000
- Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998Journal of Antimicrobial Chemotherapy, 1999
- Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance StudyAntimicrobial Agents and Chemotherapy, 1999